Worgall S, Rascher W, Gyódi G, Nyul Z, Baranyai Z, Sulyok E
Zentrum für Kinderheilkunde, Justus-Liebig-Universität, Giessen, Germany.
Biol Neonate. 1997;72(6):337-44. doi: 10.1159/000244503.
Ouabain or an isomer has been identified as endogenous ouabain-like substance (EOLS). The role of EOLS in the adaptation of premature infants to alterations of sodium balance was investigated by measuring urinary ouabain excretion serially in 9 low birth weight premature infants with (group S, mean birth weight 1,578 g, mean gestational age 30.4 weeks) and without (group NS, mean birth weight 1,537 g, mean gestational age 30.8 weeks) NaCl supplementation. The study was performed on the 7th day and weekly thereafter until the 5th week of life. NaCl supplementation was given in a dose of 3-5 and 1.5-2.5 mmol/kg/day at the postnatal ages of 8-21 and 22-35 days, respectively. Prior to NaCl supplementation, urinary ouabain excretion was similar in the two groups (146.2 +/- 16.8 pg/kg/h in group S versus 180.0 +/- 9.6 pg/kg/h in group NS) and remained at about the same level throughout the study when supplemental NaCl was provided. In infants of group NS, urinary ouabain excretion increased significantly by the 3rd week (p < 0.01) and no consistent change occurred later on. As a result, the differences in urinary ouabain excretion between the two groups proved to be significant during weeks 2-5 (p < 0.001). Essentially the same pattern of ouabain excretion was seen when it was expressed in terms of pg/mg creatinine. In infants receiving high sodium diet there was a significant positive correlation between urinary sodium and ouabain excretion. It is concluded that premature infants receiving low sodium intake have elevated EOLS excretion by the 3rd week of life. Although the relationship between ouabain and sodium excretion in supplemented premature infants suggests some physiological significance for sodium excretion, ouabain does not appear to be regulated by extracellular volume.
哇巴因或其异构体已被鉴定为内源性类哇巴因物质(EOLS)。通过连续测量9名低出生体重早产儿的尿哇巴因排泄量,研究了EOLS在早产儿适应钠平衡改变中的作用。这9名早产儿分为两组,一组(S组,平均出生体重1578克,平均胎龄30.4周)补充氯化钠,另一组(NS组,平均出生体重1537克,平均胎龄30.8周)不补充氯化钠。研究在出生后第7天进行,此后每周进行一次,直至出生后第5周。分别在出生后8 - 21天和22 - 35天给予S组和NS组氯化钠补充剂,剂量分别为3 - 5 mmol/kg/天和1.5 - 2.5 mmol/kg/天。在补充氯化钠之前,两组的尿哇巴因排泄量相似(S组为146.2±16.8 pg/kg/h,NS组为180.0±9.6 pg/kg/h),并且在提供补充氯化钠的整个研究过程中保持在大致相同的水平。在NS组婴儿中,到第3周时尿哇巴因排泄量显著增加(p < 0.01),之后没有持续变化。结果,两组之间尿哇巴因排泄量的差异在第2 - 5周期间被证明具有显著性(p < 0.001)。当以pg/毫克肌酐表示时,观察到基本相同的哇巴因排泄模式。在接受高钠饮食的婴儿中,尿钠与哇巴因排泄之间存在显著的正相关。结论是,低钠摄入的早产儿在出生后第3周时EOLS排泄量升高。尽管补充氯化钠的早产儿中哇巴因与钠排泄之间的关系表明钠排泄具有一定的生理意义,但哇巴因似乎不受细胞外液量的调节。